SPARK THERAPEUTICS
Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases. The founding team includes scientists who have led the advancement of gene therapy over the past two decades, establishing human proof of concept of the expression of gene therapy in the eye and liver. Spark’s robust pipeline includes SPK-RPE65, a fully enrolled, pivotal Phase 3 program in blindness due to mutati... ons in the RPE65 gene, SPK-CHM for the treatment of choroideremia, and SPK-FIX, a program for the potential treatment of hemophilia B through a global collaboration with Pfizer Inc., as well as preclinical programs to address neurodegenerative diseases and other retinal degenerative diseases and hematologic disorders. Spark has rights to a proprietary manufacturing platform that has a track record supporting clinical studies across diverse therapeutic areas and routes of administration. Spark’s expertise across research, clinical, regulatory and manufacturing builds on a legacy of innovation and excellence in gene therapy established by Spark’s team while at The Children’s Hospital of Philadelphia Center for Cellular and Molecular Therapeutics.
SPARK THERAPEUTICS
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2013-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.sparktx.com
Total Employee:
51+
Status:
Active
Contact:
1(855)772-7589
Email Addresses:
[email protected]
Total Funding:
122.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Repros Therapeutics
Repros Therapeutics is focused on the development of new drugs to treat hormonal and reproductive system disorders.
Resolve Therapeutics
Resolve Therapeutics is focused on developing a novel approach to the treatment of Systemic Lupus Erythematosus (SLE).
Revitope Oncology
Revitope is developing a novel approach to cancer immunotherapy.
New England Biolabs
New England Biolabs is focused on the discovery and development of recombinant and native enzymes for genomic research.
Natera
Natera specializes in cell-free DNA testing to elevate the science and utility of prenatal testing.
Neos Therapeutics
Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.
Vasopharm
Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms.
Vigene Biosciences
Vigene develops gene delivery technologies with the mission to advance biomedical research and to make gene therapy affordable.
Vicus Therapeutics
Vicus Therapeutics is a biopharmaceutical company, providing treatments to patients with cancer.
Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp.
LogicBio Therapeutics
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
Lacerta Therapeutics
Lacerta Therapeutics is a clinical stage gene therapy company.
Arisaph Pharmaceuticals
Arisaph Pharmaceuticals is focused on the development of therapies for cancer, cardiovascular disease, and diabetes.
Axent Biosciences
Axent Biosciences is a biotech venture that engineers biomaterial technology for the development pipeline of stem cell therapy.
AmpliPhi Biosciences
AmpliPhi Biosciences is focused on developing novel bacteriophage-based therapeutics.
Aegle Therapeutics
Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
AmbAgon Therapeutics
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
Advanced Proteome Therapeutics
Advanced Proteome Therapeutics is focused on the development of novel therapeutics for the treatment of cancerous tumors.
eXIthera Pharmaceuticals
ExIthera Pharmaceuticals supports the creation of antithrombotic and stroke prevention medications.
Exalys Therapeutics
Exalys Therapeutics is focused on the development of first-in-class therapies for the treatment of inflammatory disorders.
Envisagenics
Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.
BEAT BioTherapeutics
BEAT BioTherapeutics develops novel therapies for heart diseases.
Bioincept
BioIncept develops compound for embryo development in humans.
Bedrock Therapeutics
Bedrock Therapeutics is an AAV research and Development Gene Therapy Company.
Trigemina
Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.
Telo Therapeutics
Telo Therapeutics is a novel precision medicine approach to reverse cancer cell immortality.
Tizona Therapeutics
Tizona develops next-generation immunotherapies
TenNor Therapeutics
TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases
T3D Therapeutics
T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.
Therabron
Therabron Therapeutics, we are working to change how respiratory diseases are managed.
JSK Therapeutics
JSK Therapeutics is in order to develop new anti-cancer therapeutics
Winston Pharmaceuticals
Winston Pharmaceuticals is engaged in the development of pain management products.
1E Therapeutics
1E Therapeutics is a breakthrough, drug development company.
SymbioCellTech
Research and development company in biotechnology aiming for a functional cure to diabetes through patented Neo-Isletsâ„¢ technology
SiteOne Therapeutics
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.
Sideris Pharmaceuticals
Sideris Pharmaceuticals is focused on the development of therapeutics for the treatment of transfusion-related iron overload.
SalioGen Therapeutics
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.
Synthekine
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Sino-Biocan
Sino-Biocan focuses on the research and development of domestic tools in the field of cell and gene therapy.
Horizon Pharma
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
ImStar Therapeutics
ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis.
Atomica Corp
Atomica is the largest US MEMS foundry supporting the full spectrum of MEMS, including photonics, sensors and microfluidic biochips.
Incisive Genetics
Incisive Genetics is developing a delivery platform for genetic therapies.
Immutrix Therapeutics
Immutrix Therapeutics is a medical tech company that has developed a medical device for cleansing the blood.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
GLyPharma Therapeutic
GLyPharma Therapeutic Inc. develops oncology drugs.
Opexa Therapeutics
Opexa Therapeutics develops patient-specific immunotherapies for the treatment of multiple sclerosis.
Orthogon Therapeutics
Orthogon Therapeutics is a drug development company.
Orpro Therapeutics
OrPro Therapeutics develops recombinant thioredoxin for the treatment of cystic fibrosis.
Otolith Labs
First Therapeutic Device For The Treatment Of Vertigo.
Cairn Therapeutics
Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies.
CryoTherapeutics
CryoTherapeutics is focusing on the development, demonstration of clinical benefit & commercialization of a proprietary cryotherapy system.
Plus Therapeutics
Plus Therapeutics is a clinical-stage pharmaceutical company that develops targeted therapies to treat cancer and other serious diseases.
Curetis
Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.
Corvidia
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
CODA Biotherapeutics
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Starton Therapeutics
Starton Therapeutics is a biotechnology company that focuses on transforming standard of care in therapeutics.
CeleCor Therapeutics
CeleCor Therapeutics develops first-point contact treatments for segment elevated myocardial infarction.
Carcell Biopharma
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.
CellCentric
CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
Chameleon Biosciences
Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.
CRISPR Therapeutics
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
ProQR Therapeutics
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
Alterity Therapeutics
Alterity Therapeutics has developed a proprietary library of class-leading chemical compounds.
PNP Therapeutics
PNP Therapeutics is engaged in the development of technology and proprietary products for the treatment of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-03-07 | Genable Technologies Ltd. | Genable Technologies Ltd. acquired by Spark Therapeutics | 15.15 M USD |
Investors List
Brookside Capital
Brookside Capital investment in Series B - Spark Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - Spark Therapeutics
Deerfield
Deerfield investment in Series B - Spark Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Spark Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - Spark Therapeutics
Wellington Management
Wellington Management investment in Series B - Spark Therapeutics
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia investment in Series A - Spark Therapeutics
Key Employee Changes
Official Site Inspections
http://www.sparktx.com Semrush global rank: 646.4 K Semrush visits lastest month: 67.55 K
- Host name: server-13-225-63-39.ewr53.r.cloudfront.net
- IP address: 13.225.63.39
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Spark Therapeutics"
Our Corporate Social Responsibility – Spark Therapeutics
Healthcare and Patient Organizations. If you are representing a healthcare organization, including a medical/scientific association, professional society, patient association, or patient advocacy group, please submit your request for …See details»
Corporate Giving Request FAQs - sparktx.com
Send to [email protected]. Please do not mail hardcopy requests. A formal Letter of Request on requesting organization's letterhead outlining the event or program for which …See details»
Spark® Therapeutics’ Sponsorships and Donations Requests Portal
If multiple people from the same organization are submitting requests, each individual will only see their own requests in the portal. If you are a civic, educational, cultural, and/or local …See details»
Spark Therapeutics - Wikipedia
The company was founded in 2013 by Katherine A. High, Jeffrey Marrazzo, and Steven Altschuler in an effort to commercially develop treatments against haemophilia that High was working on at Children's Hospital of Philadelphia. In January 2015, the company became a public company, trading under the ticker $ONCE via a $161 million initial public offering led by Chief Legal Officer Joseph La Barge. See details»
Spark Therapeutics
If you are a Healthcare Professional or Healthcare Organization, including a medical/scientific association, professional society, patient association, or patient advocacy group, please …See details»
Spark Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 215-220-9300 Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating …See details»
Spark Therapeutics, Inc. | LinkedIn
Spark Therapeutics, Inc. Biotechnology Research Philadelphia, PA 90,921 followers Our mission is to unlock the power of gene therapy to accelerate healthcare transformation.See details»
Dir, Infrastructure Service Management - careers.sparktx.com
This role will monitor the overall service performance and quality provided by the Infrastructure & Security (I&S) organization and its partners ensuring that compliance, deliverables, and …See details»
Company Overview - sparktx.com
Company Overview Spark Therapeutics, a fully integrated company, strives to challenge the inevitability of genetic disease by working to discover, develop and deliver gene therapies that …See details»
Dir, Enterprise & Data Architecture - careers.sparktx.com
Nov 23, 2024 This role leads, prioritizes and develops the overall enterprise and data architecture approach for the organization, and communicates architectural direction. He / she …See details»
Executive Administrative Assistant - PSO & Commercial
Nov 13, 2024 With a dual-reporting line to the Head of PSO (Patient Supply Organization) and the Head of Commercial, provides support to multiple executives and departments in a fast …See details»
Spark Therapeutics - Overview, News & Similar companies
Www.sparktx.com. Revenue $236.3 Million. Industry Pharmaceuticals Healthcare . Most Recent Scoops. Aug 18 2024. Open Position. Jul 21 2024. ... Explore Complete Organization …See details»
About Us - Spark
As we secure a solid foundation for our organization, not only will we have the means to invite the community in but we will have the ability to mobilize and bring our programs out to high risk …See details»
Spark Therapeutics to Invest $575M in New 500k Square Foot
Dec 17, 2021 More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, …See details»
Media – Spark Therapeutics
Media. Learn more about Spark® Therapeutics’ progress and explore our recent announcements and resources. For additional media inquiries, please contact: [email protected] …See details»
Spark Therapeutics and CombiGene Enter into Exclusive,
Oct 12, 2021 CombiGene and Spark have had a productive ongoing dialogue during the latter parts of CG01’s preclinical development, and the entire CombiGene team have come to know …See details»
Our Scientific Platform and Programs – Spark Therapeutics
Innovative scientific and regulatory strategies. We work in a spirit of collaboration with investigators and regulators to develop rigorous and novel endpoints that measure the …See details»
Spark Therapeutics Announces Updated Phase 1/2 Study Results …
Dec 12, 2022 “The updated results of this Phase 1/2 study add to the growing body of preliminary evidence suggesting that investigational SPK-8011 provides durable FVIII …See details»
Join the Spark Team – Spark Therapeutics
Join the Spark® Team. We have grown from a team of three to a dynamic organization with hundreds of talented individuals working together to unlock the power of gene therapy to …See details»